CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.
about
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 proteinFas-ligand: privilege and perilHigh-risk corneal allografts: A therapeutic challengeInflammation and its role in age-related macular degenerationCorneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cellsHemophagocytic macrophages harbor Salmonella enterica during persistent infectionImmune privilege: keeping an eye on natural killer T cells.Immunogenic and tolerogenic cell death.Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis.Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression.Pseudorabies virus-induced leukocyte trafficking into the rat central nervous systemRegulation of Fas-mediated apoptosis in CD2-fas transgenic mice.Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans.Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance.Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR.Fas and Fas ligand in gut and liver.Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism.Targeting immune privilege to prevent pathogenic neovascularizationIs pancreas development abnormal in the non-obese diabetic mouse, a spontaneous model of type I diabetes?PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction.Mechanisms of immune privilege in the posterior eye.Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells.Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degenerationArmed response: how dying cells influence T-cell functions.Cell death and immune privilege.Recent developments in the pharmacological treatment and prevention of corneal graft rejection.The potential of antibody-based immunosuppressive agents for corneal transplantation.Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins.Apoptosis and transplantation tolerance.Facets of heat shock protein 70 show immunotherapeutic potential.Recognition and phagocytosis of apoptotic T cells by resident murine tissue macrophages require multiple signal transduction events.Fas ligand upregulation is an early event in colonic carcinogenesis.Management of high-risk corneal grafts.Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1The adaptive immune system in diseases of the central nervous system.
P2860
Q24314282-558F7FAB-56AC-4311-BC16-F39128723C9BQ24612227-D61306CC-D760-4F94-A555-58F8F027BC56Q26751483-2BCF4F26-2024-482A-8548-1E740A6CB5C1Q26768520-FBB9D2E1-6AD2-4968-A9E2-6219D50222A7Q26823757-B65E78C2-8885-46D0-9EF1-EE2985ADB7BDQ26999223-7DB42283-CDB1-4895-BF7A-FBE5C55B6FDCQ27319444-F20B2E30-97A8-466B-9B2F-943E1138A7C3Q30050558-DA372814-B90F-4DAA-9482-13F647A8D784Q33639097-65EE387A-3546-48C9-91DA-380A4D08F76BQ33713307-8E40C99A-5515-4781-B5C9-A9BE543C3C5CQ33774541-0C67E5B1-D7C4-45B4-9EBF-EC2E77560234Q33785423-959806B2-3FF8-4558-8C07-FD5E7AE8E059Q33811729-AC5FFB26-4584-4BE6-BC19-6475E3308B77Q33826410-8A983E3F-FFD9-4D9B-8A15-01CEC3DA1068Q33836332-B3E9B008-67D5-4EF8-B0D6-28E2280CD3A1Q33838748-EA7B8B1E-8F50-4FD9-B826-908662F42B32Q33860215-2333D140-E2D2-441F-998F-5FBB365ABE6DQ33918905-39709E8E-1801-4C85-9A18-CC2198486B70Q33994168-21F9C72D-F657-45CE-B64A-6E12ED9E6EA9Q34206509-2BA9307A-8B01-4335-B64D-42CD971768BDQ34378721-A4B9F3AC-3604-4ACA-BB62-C9A3E8A5B8F4Q34378771-729CD788-B2AD-425B-89CA-502935B3C099Q34415756-CEEFA128-6BA2-41D4-98E2-968C82DC392AQ34560654-B9DE1E02-E2E0-4CCF-9139-7119A722F170Q34566740-BBB4D2AA-3304-4B6C-B9BB-A7BF60C788B4Q34786879-AAD959F7-949B-4E54-B27C-D0A1D2C959CFQ34791186-4B0951C9-20E0-4696-AD44-C378AE1C5459Q34992210-E9F16D26-E8D1-49B5-860F-EA26A05B1509Q34993208-788212F3-6D23-48F2-AB0D-79B0E58B1E1DQ35040789-BC3778DF-AA71-4782-961E-DE028D033926Q35083644-2BFF9034-AAA2-49F4-8113-3A365FD0EB72Q35097949-4CE3AAC2-1E8C-4D74-8D75-DF9D2148F657Q35129731-788AF725-B5D7-47E5-A308-5FBCE96E8E3DQ35129735-468EE0F4-01C3-4305-A595-52EED706F99FQ35206769-2FFE30D9-26CC-4533-AACE-794FE894ED2EQ35212294-B234E4A4-B516-46D1-9934-933722ED31F9Q35399449-644FEC14-4920-4612-A446-E509D57BFD2CQ35590428-1C9FEEA4-7DEF-442D-A747-9E9CBFCF85D7Q35658941-F8695492-0C00-4DBF-94BA-294C14397729Q35858036-8DB07581-7452-4645-BF8E-6676DDEFCEED
P2860
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@en
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@nl
type
label
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@en
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@nl
prefLabel
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@en
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@nl
P2093
P1433
P1476
CD95-induced apoptosis of lymp ...... duces immunological tolerance.
@en
P2093
P356
10.1016/S1074-7613(00)80305-2
P407
P577
1996-07-01T00:00:00Z